Clinical Trial Update: A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of different orally administered regimens of the ZY19489-Ferroquine combination in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Ferroquine (ferroquine)
• ZY19489

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Uncomplicated Malaria, Asymptomatic Condition | Phase 1 | Status: RECRUITING